Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 5:
6. The compound of claim 3, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2 is C1-C5 alkyl, wherein the C1-C5 alkyl is optionally substituted by 1, 2, 3, 4, or 5 independently selected R2a substituents; and
each R2a is halogen, CN, C1-C6 alkyl, NR6R7, NR5C(O)OR6, OR5, S(O)2R5, C3-C8 cycloalkyl, 3- to 12-membered heterocyclyl, C6-C14 aryl, or 5- to 10-membered heteroaryl, wherein each C1-C6 alkyl, C3-C8 cycloalkyl, 3- to 12-membered heterocyclyl, C6-C14 aryl, and 5- to 10-membered heteroaryl is optionally and independently substituted by 1 or more independently selected R4a substituents.